Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Lithium and Acetate for Canavan Disease
This study has been suspended.
( suspended we do not received authorization for Triacetin from Health Authorities )
Study NCT00657748 Information provided by Assistance Publique - Hôpitaux de Paris
First Received: April 9, 2008 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Canavan Disease
Infantile
Deficiency Disease
Aspartoacylase
Leukodystrophy, Spongiform
Additional conditions recognized in this trial
Deficiency Diseases
More general conditions related to this trial
Demyelinating Diseases
Genetic Diseases, Inborn
Hereditary Central Nervous System Demyelinating Diseases
Heredodegenerative Disorders, Nervous System
Malnutrition
Nervous System Diseases
Neurodegenerative Diseases
Nutrition Disorders
Additional drug interventions recognized in this trial
Lithium
Lithium Carbonate
Triacetin
More general drug interventions related to this trial
Anti-Infective Agents
Antidepressive Agents
Antifungal Agents
Antimanic Agents
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris
European Leukodystrophy Association
Back to top of Main Content
